132 related articles for article (PubMed ID: 9253748)
1. A rapid electron-capture gas chromatographic method for the quantification of fluvoxamine in brain tissue.
Rotzinger S; Todd KG; Bourin M; Coutts RT; Baker GB
J Pharmacol Toxicol Methods; 1997 Apr; 37(3):129-33. PubMed ID: 9253748
[No Abstract] [Full Text] [Related]
2. Electroanalytical study of fluvoxamine.
Nouws HP; Delerue-Matos C; Barros AA; Rodrigues JA; Santos-Silva A
Anal Bioanal Chem; 2005 Aug; 382(7):1662-8. PubMed ID: 15983767
[TBL] [Abstract][Full Text] [Related]
3. Determination of fluoxetine, fluvoxamine, and clomipramine in pharmaceutical formulations by capillary gas chromatography.
Berzas Nevado JJ; Villaseñor Llerena MJ; Contento Salcedo AM; Aguas Nuevo E
J Chromatogr Sci; 2000 May; 38(5):200-6. PubMed ID: 10813517
[TBL] [Abstract][Full Text] [Related]
4. A fluvoxamine-related fatality: Case report with postmortem concentrations.
Otter J; McIntyre IM; Morhaime J; Cantrell L
Forensic Sci Int; 2019 Jul; 300():e31-e33. PubMed ID: 30871740
[TBL] [Abstract][Full Text] [Related]
5. Intracerebroventricular fluvoxamine administration inhibited pain behavior but increased Fos expression in affective pain pathways.
Hayashi T; Miyata M; Nagata T; Izawa Y; Kawakami Y
Pharmacol Biochem Behav; 2009 Jan; 91(3):441-6. PubMed ID: 18817806
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of pharmaco-EEG in depression treated with fluvoxamine].
Wiśniewski G; Jakitowicz J; Nowicki Z
Psychiatr Pol; 2002; 36(6 Suppl):109-14. PubMed ID: 12647429
[TBL] [Abstract][Full Text] [Related]
7. Antidepressant-like effect of coadministration of sulpiride and fluvoxamine in mice.
Ago Y; Harasawa T; Itoh S; Nakamura S; Baba A; Matsuda T
Eur J Pharmacol; 2005 Sep; 520(1-3):86-90. PubMed ID: 16140294
[TBL] [Abstract][Full Text] [Related]
8. Determination of four selective serotonin reuptake inhibitors by capillary isotachophoresis.
Buzinkaiová T; Polonský J
Electrophoresis; 2000 Aug; 21(14):2839-41. PubMed ID: 11001291
[TBL] [Abstract][Full Text] [Related]
9. [New antidepressive agents].
LaBranche S
Union Med Can; 1995 Nov; 124(3):8-13. PubMed ID: 8560639
[No Abstract] [Full Text] [Related]
10. Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders.
Strauss WL; Unis AS; Cowan C; Dawson G; Dager SR
Am J Psychiatry; 2002 May; 159(5):755-60. PubMed ID: 11986128
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat.
Geldof M; Freijer J; van Beijsterveldt L; Danhof M
Pharm Res; 2008 Apr; 25(4):792-804. PubMed ID: 17710515
[TBL] [Abstract][Full Text] [Related]
12. Serotonin syndrome and fluvoxamine: a case study.
Bastani JB; Troester MM; Bastani AJ
Nebr Med J; 1996 Apr; 81(4):107-9. PubMed ID: 8628448
[TBL] [Abstract][Full Text] [Related]
13. Determination of citalopram in fish brain tissue: benefits of coupling laser diode thermal desorption with low- and high-resolution mass spectrometry.
Borik A; Staňová AV; Brooks BW; Grabicová K; Randák T; Grabic R
Anal Bioanal Chem; 2020 Jul; 412(18):4353-4361. PubMed ID: 32372276
[TBL] [Abstract][Full Text] [Related]
14. Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites.
Unceta N; Goicolea MA; Barrio RJ
Biomed Chromatogr; 2011 Jan; 25(1-2):238-57. PubMed ID: 21058412
[TBL] [Abstract][Full Text] [Related]
15. Photo-isomerization of fluvoxamine in aqueous solutions.
Kwon JW; Armbrust KL
J Pharm Biomed Anal; 2005 Apr; 37(4):643-8. PubMed ID: 15797783
[TBL] [Abstract][Full Text] [Related]
16. Development of a fluvoxamine detection system using a Quenchbody, a novel fluorescent biosensor.
Sasao A; Takaki M; Jeong HJ; Yonemitsu K; Ohtsu Y; Tsutsumi H; Furukawa S; Morioka H; Ueda H; Nishitani Y
Drug Test Anal; 2019 Apr; 11(4):601-609. PubMed ID: 30328685
[TBL] [Abstract][Full Text] [Related]
17. Application of chrome azurol S for the extractive spectrophotometric determination of fluoxetine and fluvoxamine.
Starczewska B; Mielech K
J Pharm Biomed Anal; 2000 Aug; 23(2-3):243-7. PubMed ID: 10933516
[TBL] [Abstract][Full Text] [Related]
18. Investigation and analytical application of the reactions of eriochrome cyanine R with fluvoxamine and fluoxetine.
Starczewska B; Puzanowska-Tarasiewicz H; Baranowska K
J Pharm Biomed Anal; 2000 Aug; 23(2-3):477-81. PubMed ID: 10933541
[TBL] [Abstract][Full Text] [Related]
19. Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
Salgado-Petinal C; Lamas JP; Garcia-Jares C; Llompart M; Cela R
Anal Bioanal Chem; 2005 Jul; 382(6):1351-9. PubMed ID: 15986209
[TBL] [Abstract][Full Text] [Related]
20. Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.
Satoh K; Takano S; Onogi T; Ohtsuki K; Kobayashi T
Fukushima J Med Sci; 2006 Jun; 52(1):29-33. PubMed ID: 16995352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
